Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Currently, COPD-marketed therapy leaders include GSK’s Trelegy Ellipta, which is set to grow in sales to $2.16bn by 2033.

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

Two posters presented at the CHEST 2024 annual meeting underscore the importance of early identification and treatment of ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

Inhaled nitric oxide device INOmax Evolve DS is now available for U.S. hospitals to use on newborns, Mallinckrodt ...

Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...

Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...